Latest news with #enzymeengineering
Yahoo
12-06-2025
- Business
- Yahoo
Industrial Enzymes Market worth $12.01 billion by 2030- Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., June 12, 2025 /PRNewswire/ -- The industrial enzymes market is estimated at USD 8.42 billion in 2025 and is projected to reach USD 12.01 billion by 2030, at a CAGR of 7.3% from 2025 to 2030, according to a report published by MarketsandMarkets™. The industrial enzymes market is expected to grow steadily in the coming years due to increasing demand for sustainable, efficient, and cost-effective processing solutions across core manufacturing sectors. As industries face growing pressure to reduce environmental impact, enzymes offer a bio-based alternative to conventional chemical processes, operating under mild conditions and lowering energy and water consumption. Sectors such as food & beverage, textiles, bioethanol, detergents, and wastewater treatment are adopting enzyme-driven processes to enhance product quality, improve yield, and meet tightening regulatory standards. Additionally, advancements in enzyme engineering, fermentation technology, and immobilization techniques are expanding enzyme applicability and performance under harsh industrial environments. The shift toward circular economy models and bio-based production, supported by government initiatives in regions like Europe, India, and Southeast Asia, is further accelerating enzyme adoption. With rising demand for cleaner, more efficient manufacturing, industrial enzymes are positioned to become integral to future industrial value chains globally. Browse in-depth TOC on "Industrial Enzymes Market" 150– Tables130– Figures300– Pages Download PDF Brochure: Microorganisms hold the largest share within the source segment. Microorganism-based enzymes dominate the industrial enzymes market due to their high efficiency, scalability, and adaptability across diverse industrial applications. Enzymes derived from bacteria and fungi—particularly Bacillus and Aspergillus species—are favored for their ability to function under a broad range of temperatures and pH levels, making them suitable for sectors such as food processing, bioethanol, detergents, and textiles. Microbial fermentation processes allow for large-scale, cost-effective enzyme production with consistent quality and high yield. Furthermore, microorganisms can be genetically modified to enhance enzyme specificity, stability, and activity, enabling tailored solutions for industry-specific needs. Continuous innovations in strain improvement and fermentation technology are strengthening the commercial viability of microbial enzymes. Unlike plant- or animal-derived enzymes, microbial enzymes also face fewer supply chain constraints and are easier to standardize for industrial use. Their strong alignment with sustainability, process efficiency, and regulatory compliance makes microbial sources the most preferred and dominant category in the industrial enzymes landscape. The wastewater treatment segment is emerging as the fastest-growing category within the global industrial enzymes market The wastewater treatment segment is rapidly emerging as the fastest-growing application within the industrial enzymes market, driven by escalating environmental regulations and the global imperative for sustainable water management. Enzymes offer a biodegradable and efficient alternative to conventional chemical treatments, effectively breaking down organic pollutants, fats, oils, and complex compounds in municipal and industrial effluents. This enzymatic approach not only reduces the reliance on harsh chemicals but also minimizes sludge production, leading to lower disposal costs and enhanced treatment efficiency. The surge in industrialization and urbanization has intensified the volume and complexity of wastewater, necessitating advanced treatment solutions. Enzymatic treatments address these challenges by providing targeted action against specific contaminants, ensuring compliance with stringent discharge standards. Furthermore, innovations in enzyme engineering have led to the development of robust enzymes capable of operating under diverse environmental conditions, enhancing their applicability across various wastewater treatment scenarios. As industries and municipalities strive for eco-friendly and cost-effective wastewater solutions, the adoption of enzyme-based treatments is poised to accelerate, solidifying this segment's growth trajectory in the industrial enzymes market. A notable development in this field occurred in May 2025, when researchers at the National Institute of Technology, Rourkela (NIT-R), introduced an eco-friendly and cost-effective wastewater treatment system utilizing sunlight and reusable spherical concrete beads as photocatalysts. This innovative approach achieved over 82% reduction in Chemical Oxygen Demand (COD) in simulated wastewater under sunlight and maintained over 90% efficiency after 15 reuse cycles. The system's reliance on natural sunlight eliminates the need for artificial UV light, making it highly energy-efficient and sustainable, particularly suitable for rural and resource-constrained regions. The findings have been published in the Journal of Water Processing Engineering, and two patents have been filed. Request Sample Pages: Based on region, Asia Pacific is estimated to be the dominating region in the industrial enzymes market. Asia Pacific is currently the leading region in the industrial enzymes market, driven by rapid industrialization, expanding manufacturing sectors, and increasing regulatory emphasis on sustainable processing. Countries such as China, India, and Southeast Asian nations are witnessing strong growth across key enzyme-consuming industries, including food and beverage, textiles, biofuels, and wastewater treatment. The region's large population base and rising consumer demand for processed and packaged foods have fueled the use of food-grade enzymes, while urbanization and environmental concerns have prompted industries to adopt enzyme-based solutions for water treatment and pollution control. Government support for biotechnology and bioeconomy development, such as India's BioE3 policy launched in August 2024, has further accelerated local enzyme production and innovation. Additionally, the availability of low-cost raw materials, skilled labor, and favourable investment environments has attracted key players to establish production and R&D facilities in the region. These structural and policy-driven advantages position Asia Pacific as the dominant and fastest-expanding region in the global industrial enzymes landscape.A notable development in this field occurred in March 2024, when Novus International, Inc. acquired US-based enzyme company BioResource International, Inc., gaining ownership of BRI's products, intellectual property, and facilities. This acquisition will enhance customer service, expand their innovation pipeline, and provide more options for feed additives to support animal health and profitability. The report profiles key players such as BASF SE (Germany), International Flavors & Fragrances Inc. (US), DSM-Firmenich (Switzerland), Kerry Group plc. (Ireland), Dyadic International Inc (US), Advanced Enzyme Technologies (India), Aumgene Biosciences (India), Amano Enzyme Inc (Japan), Associated British Foods plc (England), Novozymes A/S (Denmark), F. Hoffmann-La Roche Ltd (Switzerland), Codexis, Inc. (US), Sanofi (France), Merck KGaA (Germany), and Adisseo (China). Get 10% Free Customization on this Report: Browse Adjacent Reports @ Food and Beverage Market Research Reports & Consulting Related Reports: Feed Enzymes Market by Type (Phytase, Carbohydrase, and Protease), Livestock (Poultry, Swine, Ruminants, and Aquatic Animals), Source (Microorganism, Plant, and Animal), Form (Dry and Liquid), and Region - Global Forecast to 2025 Food Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases), Source, Application (Food & Beverages), Formulation, and Region (North America, Europe, Asia Pacific, and South America) - Global Forecast to 2026 About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets Inc.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Insight: Our Website: Source: Logo: View original content: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
28-05-2025
- Business
- Associated Press
Enginzyme Appoints Aymeric de Gantès as New CEO
STOCKHOLM--(BUSINESS WIRE)--May 28, 2025-- Enginzyme AB, a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology, announced Tuesday that it had appointed Aymeric de Gantès as CEO. Founder Karim Engelmark Cassimjee will develop a new position as Chief Innovation Officer. This press release features multimedia. View the full release here: Aymeric de Gantès De Gantès comes to enginzyme from Ingredion, a leading multinational food-ingredients company, where he was Global Program Director for Taste Modulation. 'Aymeric is the perfect fit as we position ourselves to accelerate revenue growth,' Cassimjee said. 'He proved that he understands precision technology like enginzyme's from the food-ingredients perspective by building an internal start-up to significant size. We want to apply that knowledge to our business.' 'Enginzyme's team has demonstrated that its technology can deliver what it promises, and without a 'green premium' or resource-heavy up-front investment,' De Gantès said. 'Enzyme-based chemistry is reaching a tipping point in multiple markets. It is the right time to scale-up our technology and provide attractive market solutions.' Enginzyme has developed clean, streamlined processes with major players in the food oil industry, as well as in fragrances and flavors, personal care and pharmaceuticals. Chatarina Schneider, Chair of the Board of Directors, said: 'In hiring Aymeric de Gantès, the board aims to convert the strength of enginzyme's science into significant revenue. We are confident he is the right person to take enginzyme into this new stage of development.' About enginzyme Enginzyme is enabling the shift to biomanufacturing by unlocking the power of enzymes for more cost-efficient and sustainable production of everyday products. Our patented enzyme immobilization technology enables biomanufacturing without living organisms. It can be deployed using the same tools and techniques used in traditional chemical manufacturing, with lower costs and a much smaller environmental footprint. Based in Stockholm, enginzyme is a multidisciplinary team of experts in biocatalysis, organic chemistry, enzyme and process engineering, as well as AI and machine learning. This elite team partners with global manufacturers in industries including food, pharma, and personal care to develop complete processes from techno-economic analysis all the way to industrial manufacture, incorporating a high degree of automation for safe, rapid, and reliable development. View source version on CONTACT: Press Contact James Connell [email protected] KEYWORD: SWEDEN EUROPE INDUSTRY KEYWORD: TECHNOLOGY BIOTECHNOLOGY RETAIL FOOD TECH CHEMICALS/PLASTICS HEALTH MANUFACTURING PHARMACEUTICAL ARTIFICIAL INTELLIGENCE OTHER SCIENCE ENVIRONMENT SUSTAINABILITY SCIENCE FOOD/BEVERAGE SOURCE: Enginzyme AB Copyright Business Wire 2025. PUB: 05/28/2025 09:13 AM/DISC: 05/28/2025 09:12 AM
